BlackRock Institutional Trust’s Celldex Therapeutics CLDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | $9.7M | Buy |
182,665
+22,959
| +14% | +$1.22M | ﹤0.01% | 2418 |
|
|
2016
Q3 | $9.68M | Buy |
159,706
+1,516
| +1% | +$91.9K | ﹤0.01% | 2348 |
|
|
2016
Q2 | $10.4M | Sell |
158,190
-375
| -0.2% | -$24.7K | ﹤0.01% | 2266 |
|
|
2016
Q1 | $8.99M | Sell |
158,565
-1,948
| -1% | -$110K | ﹤0.01% | 2324 |
|
|
2015
Q4 | $37.8M | Buy |
160,513
+6,950
| +5% | +$1.63M | 0.01% | 1435 |
|
|
2015
Q3 | $24.3M | Sell |
153,563
-853
| -0.6% | -$135K | ﹤0.01% | 1697 |
|
|
2015
Q2 | $58.4M | Sell |
154,416
-44,940
| -23% | -$17M | 0.01% | 1209 |
|
|
2015
Q1 | $83.3M | Buy |
199,356
+47,602
| +31% | +$19.9M | 0.01% | 1029 |
|
|
2014
Q4 | $41.5M | Sell |
151,754
-8,821
| -5% | -$2.41M | 0.01% | 1411 |
|
|
2014
Q3 | $31.2M | Sell |
160,575
-4,354
| -3% | -$846K | 0.01% | 1588 |
|
|
2014
Q2 | $40.4M | Buy |
164,929
+986
| +0.6% | +$241K | 0.01% | 1463 |
|
|
2014
Q1 | $43.5M | Buy |
163,943
+4,781
| +3% | +$1.27M | 0.01% | 1389 |
|
|
2013
Q4 | $57.8M | Buy |
159,162
+12,681
| +9% | +$4.61M | 0.01% | 1166 |
|
|
2013
Q3 | $77.8M | Sell |
146,481
-4,641
| -3% | -$2.47M | 0.02% | 931 |
|
|
2013
Q2 | $35.4M | Buy |
+151,122
| New | +$35.4M | 0.01% | 1375 |
|